Naturally Splendid (TSXV:NSP) announced that their majority owned subsidiary, POS BPC Manufacturing Corp., is in the final stages of scaling up the Bio Processing Centre at Innovation Place   in order to resume production during the last week of March 2016.
As quoted in the press release:

he 12,000-square-foot POS / BPC Facility — which is managed for POS BPC by POS Bio-Sciences — will, after operations resume, be in a position to offer commercial-scale custom processing solutions for biological materials, such as functional foods and natural health ingredients. As a result of its 2015 acquisition of POS BPC, NSE has the ability, working in conjunction with POS Bio-Sciences, to seamlessly coordinate the entire plant-to-product process by utilizing the expertise of POS Bio-Science’s R&D scientists; from sourcing bioactive, plant-based ingredients, to overseeing toll processing, to formulation, and to creating unique custom ingredient solutions, The relationship among POS BPC, POS Bio-Sciences, and NSE provides Naturally Splendid with the unique opportunity of offering clients the convenience of comprehensive solutions and services.
The POS / BPC Facility contains approximately 60,000L of tankage, a fractional distillation system, evaporation equipment, spray drying equipment, a ring dryer and various other pieces of complementary and auxiliary equipment. It is capable of processing a variety of products including, among others, the suite of plant-based omega technologies such as HempOmega® (www.hempomega.com). Additionally, the POS / BPC Facility is designed to produce plant-based extracts, tinctures and dry ingredients for a variety of clients.


Naturally Splendid Co-Founder, Bryan Carson, stated:

Naturally Splendid’s strategic decision to acquire 51% of POS BPC and gain access to the POS / BPC Facility positions Naturally Splendid to compete in the rapidly growing food, beverage, cosmetic, pet care and livestock ingredients industries.

Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less